Development of H51Y and E157Q mutations for integrase inhibitor resistance in a patient undergoing treatment for pulmonary tuberculosis: A case report.
Luís Arthur Brasil Gadelha FariasMelissa Fiuza SaboyaNatália Ponte FernandesLauro Vieira Perdigão NetoErico Antonio Gomes de ArrudaPublished in: SAGE open medical case reports (2023)
Attention when determining the antiretroviral therapy treatment regimen of HIV/TB coinfected patients is paramount. Poor adherence to antiretroviral therapy and follow-up may have contributed to treatment failure and resistance.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- pulmonary tuberculosis
- end stage renal disease
- hiv aids
- mycobacterium tuberculosis
- hiv infected patients
- chronic kidney disease
- type diabetes
- newly diagnosed
- ejection fraction
- adipose tissue
- hepatitis c virus
- combination therapy
- working memory
- peritoneal dialysis
- case report
- weight loss
- patient reported outcomes
- smoking cessation